Latest filing published 03 Aug 2024 for Newbury Pharmaceuticals AB.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Andreas Hedskog: trading record in brief
This profile gathers the share dealings of Andreas Hedskog in Newbury Pharmaceuticals AB. In total, 3 filings cover trades dated from 10 February 2023 to 3 August 2024.
On the open market, the record shows 1 purchase worth €15k and 1 sale worth €49k. Netting one side against the other leaves €34k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant. Since January 2024: 1 purchase and no sales on the market.
The record was last updated on 3 August 2024 with a share grant in Newbury Pharmaceuticals AB. The clock since the last published purchase (3 August 2024) now reads 827 days. Most trades are made public on the day they happen. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Andreas Hedskog
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 200,000 shares0WarrantISIN SE0015244884FI:csv-9a6be32c6694b428a219
- 200,000 shares@ SEK 0.8923.7% of flowWarrantISIN SE0015244884FI:csv-7a45e0175638ac451d47Canonical exit: 1 Nov 2024 (T+90)
- 100,000 shares@ SEK 5.5076.3% of flowAktieISIN SE0015244884FI:csv-b447340fa414d54e765e
3 of 3 declarations